Submission Details
| 510(k) Number | K071525 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 2007 |
| Decision Date | March 19, 2008 |
| Days to Decision | 289 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K071525 is an FDA 510(k) clearance for the ACTIVATED ASPARTATE AMINOTRANSFERASE, a Nadh Oxidation/nad Reduction, Ast/sgot (Class II — Special Controls, product code CIT), submitted by Abbott Laboratories (Irving, US). The FDA issued a Cleared decision on March 19, 2008, 289 days after receiving the submission on June 4, 2007. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1100.
| 510(k) Number | K071525 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 04, 2007 |
| Decision Date | March 19, 2008 |
| Days to Decision | 289 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | CIT — Nadh Oxidation/nad Reduction, Ast/sgot |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1100 |